Dr. Rosenthal was a panelist for the Forum’s discussion on Drug Pricing.
Meredith Rosenthal, PhD, is Professor of Health Economics and Policy and the Associate Dean of Diversity at the Harvard T.H. Chan School of Public Health. She is a member of the Massachusetts Public Health Council and an elected board chair of the Massachusetts Health Quality Partners.
Dr. Rosenthal’s research focuses primarily on policies that will help slow the growth in healthcare spending. These efforts include changes in payment incentives, benefit design, and the provision of information and behavioral “nudges” to both patients and providers. Her research has influenced the design of provider payment systems in both the public and private sectors. She has advised federal and state policymakers in healthcare payment policy and implementation. She has also testified in Congressional hearings on direct-to-consumer advertising of prescription drugs and pay-for-performance and in legislative hearings in California and Massachusetts concerning healthcare provider payment and benefit design policies. During the 2008 presidential campaign and post-election transition, she provided policy analyses to Barack Obama’s healthcare team regarding opportunities for Medicare payment reform, pay for performance, and cost control. Her work has been published in The New England Journal of Medicine, the Journal of the American Medical Association, Health Affairs, and numerous other peer-reviewed journals.